Methocarbamol Patent Expiration

Methocarbamol was first introduced by Endo Operations Ltd in its drug Robaxin-750 on Approved Prior to Jan 1, 1982. Other drugs containing Methocarbamol are Robaxin, Atmeksi. 54 different companies have introduced drugs containing Methocarbamol.


Methocarbamol Patents

Given below is the list of patents protecting Methocarbamol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Atmeksi US12390439 Oct 09, 2044 Rosemont Pharms



Methocarbamol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Methocarbamol Generic API Manufacturers

Several generic applications have been filed for Methocarbamol. The first generic version for Methocarbamol was by Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Mikart Llc and was approved on Jun 12, 2023.

Given below is the list of companies who have filed for Methocarbamol generic, along with the locations of their manufacturing plants worldwide.